The relationships between serum level of testosterone (T) and prostate cancer (PCa) are complex. The present study evaluated whether presence of PCa alters serum T levels. Subjects were 125 patients with clinically localized PCa treated using radical prostatectomy (RP), for whom pretreatment T levels were recorded. We investigated clinical and pathological factors such as pretreatment serum T level, age, pretreatment prostate-specific antigen, Gleason score and pathological stage. Serum T and human luteinizing hormone (LH) levels before and after RP were then compared in 118 of the 125 patients. Mean pretreatment T level was significantly higher in patients with organ-confined PCa (pT2; 4.03 ± 1.50 ng ml
Introduction
Prostate cancer (PCa) results from complex and as yet unclear interactions between aging, genetic factors, hormones, growth factors and environment. 1, 2 Hormones, particularly androgens, are believed to be important in the etiology of PCa. Several studies have identified relationships between pretreatment serum levels of testosterone (T) and both clinical stage of PCa and patient survival, suggesting that pretreatment serum T level has potential as a prognostic factor for PCa. 3, 4 The hormonal hypothesis remains one of the most important hypotheses in PCa etiology, and efforts are continuing to improve the understanding of androgen action in PCa. Although evidence from epidemiological studies of an association between circulating levels of androgens and PCa risk has been inconsistent, the traditional view that higher T represents a risk factor for PCa appears to have little evidentiary support. 5, 6 However, epidemiological and biological differences in PCa are generally believed to exist between Western and Asian men. Investigating the association between serum T levels and PCa in a Japanese population thus seems important.
In the present study of 125 Japanese patients with localized PCa who underwent radical prostatectomy (RP) as an initial treatment, we examined possible relationships between pretreatment serum T level and several clinical and pathological factors. In addition, we compared serum T and human luteinizing hormone (LH) levels before and after RP in 118 of the 125 patients, to evaluate whether the presence of PCa alters serum T levels.
Materials and methods
A total of 148 patients with PCa were treated with RP at Chiba University Hospital between January 1997 and December 2005. Serum T level was obtained on a routine basis for men before and after surgery. Of these, subjects comprised 125 patients (mean age, 65.3±5.6 years; range, 49-77 years) for whom pretreatment T levels were recorded. Patients who received neoadjuvant treatment before surgery were excluded from the study.
Serum samples for the endocrine study were taken in the morning. In 118 of the 125 patients, measurements of serum T and LH levels were performed just before and 5-8 months after RP. None of the patients included in this study were taking any medication (for example, adjuvant hormonal therapy) affecting serum hormone levels during this interval. Serum T level was measured by radioimmunoassay using a DPC total testosterone kit (Nippon DPC, Tokyo, Japan). Serum prostate-specific antigen (PSA) values were determined using a Tandem R kit (Hybritech, San Diego, CA, USA). Staging was based on the 1997 TNM classification.
All subjects underwent retropubic RP as the first-line treatment. Pathology of PCa was evaluated by wholemount step sectioning. Organ-confined disease (pT2) was defined as cancer that displayed no capsular penetration, seminal vesicle involvement or pelvic lymph node involvement. Nonorgan-confined cancer (pT3; extraprostatic disease) was defined as cancer with capsular penetration or involvement of the seminal vesicles.
Statistical analyses were performed using Student's t-test, one-way analysis of variance and the log-rank test. Values of Po0.05 were considered indicative of statistical significance.
Results
Overall pretreatment data for age and serum levels of total T and PSA are shown in Table 1 . Table 2 shows surgical factors for all 125 patients. Pathological stages were as follows: pT2a, 58 patients (46.4%); pT2b, 38 patients (30.4%); pT3a, 20 patients (16.0%); and pT3b, 9 patients (7.2%). Table 3 shows nonparametric univariate analysis of the relationship between pretreatment T and clinical and pathological factors. Mean pretreatment T level was significantly higher in patients with organ-confined PCa (pT2; 4.03 ± 1.50 ng ml
À1
) than in patients with nonorganconfined disease (pT3; 3.42 ± 1.06 ng ml À1 ; P ¼ 0.0438; Figure 1a ). In contrast, pretreatment T levels were not significantly associated with age, pretreatment PSA or pathological Gleason score.
In the 118 patients for whom postoperative data were available, serum T level was significantly increased after RP (5.60 ± 1.90 ng ml À1 ) compared to preoperative level (3.89±1.43 ng ml À1 ; Po0.0001; Figure 2a ). In parallel with T, serum LH level was significantly elevated after RP (6.86±3.64 ng ml
) compared with preoperative level (5.11 ± 2.47 ng ml
; P ¼ 0.0001; Figure 2b ). Even in analysis confined to pT2 or pT3 patients, serum T levels were significantly increased after RP (5.65 ± 1.98 and 5.40±1.64 ng ml
, respectively) compared to preoperative levels (4.03 ± 1.50 and 3.42 ± 1.06 ng ml À1 , respectively; Po0.0001; Figure 3 ). Rates of increase in serum T levels according to pathological stage were pT2 156.9% and pT3 168.7%, respectively, and no differences were identified (P ¼ 0.5242). Finally, we did not recognize any postoperative difference in serum T levels according to pathological stage (P ¼ 0.5513; Figure 1b ). Only eight patients (6.8%) had a PSA recurrence at the postoperative time point. There was no association between the presence of PSA recurrence and postoperative T levels.
Discussion
Prostatic development and growth depend on androgenic stimulation. In 1941, Huggins et al. 7 published the first report of a relationship between serum T and PCa. The association between serum T and PCa is not yet completely understood. A growing number of studies Other studies have described the relationship of lower T to more advanced disease. Recently, although only using a small study cohort, Teloken et al. 20 from Brazil reported preoperative low T level was associated with positive surgical margin in RP. Similar results were found in a recent study of a large cohort of patients also treated with RP. Massengill et al. 16 retrospectively analyzed a large cohort of 879 patients treated with RP from multiple institutions, following different parameters during several years. They showed that patients with nonorgan-confined PCa exhibit significantly lower preoperative T levels than those with organ-confined disease, and that preoperative T level is a significant predictor of extraprostatic disease in multivariate analysis. These findings have been confirmed in patients with different ethnic background by other investigators. 21, 22 Our previous study was the first to analyze T data for Japanese men with clinically localized PCa. 15 Similarly, Isom-Batz et al. 17 reported that low preoperative total T was associated with advanced pathological stage, but not with biochemical recurrence on multivariate analysis. No association between pretreatment T level and GS was shown in the reports of Massengill et al., 16 Imamoto et al. 15 and Isom-Batz et al., 17 in which study populations were limited to patients with clinically localized PCa.
The cause of the association between high-risk PCa and low serum T remains under investigation. Several hypotheses have been put forward as to why pathological stage is more advanced in men with lower T. T might be reduced secondary to chronic disease or as a consequence of advanced disease. 23 Others have suggested that PCa inhibits androgens through negative feedback of inhibin, PSA or dihydrotestosterone (DHT). 10, 24 Another theory is that with low T, the hormonal milieu might be varied enough to disrupt the normal growth and maintenance of prostatic tissue, although the compensatory hyperplasia that results when the prostate atrophies might lead to cell mutations Radical prostatectomy and serum testosterone T Imamoto et al and consequent selection of androgen-independent, aggressive prostate cells. 16, 25 One explanation for the association between low T and PCa is the apparent suppression of T by PCa by the hypothalamic-pituitary axis. Miller et al. 24 revealed that T and gonadotropin levels were significantly increased after RP. According to Lukkarinen et al., 26 these endocrine changes were not seen after simple prostatectomy for benign prostatic hypertrophy (BPH). Previous studies have shown that T, LH, and folliclestimulating hormone levels all rise following RP, but not after transurethral resection of the prostate (TURP). 24, 27 Authors have speculated that the prostate itself (at least the transition zone in BPH) does not interfere with the hypothalamic-pituitary hormone axis as far as serum hormone levels are concerned.
These results suggest that one or more factors from a normal or malignant prostate can generate negative feedback in the hypothalamus-pituitary axis. Inhibin is considered a candidate for such an inhibitory factor. Miller et al. 24 have suggested that inhibin-a produced by PCa cells might suppress the hypothalamic-pituitary axis, resulting in a lowered T level, and that a decrease in prostatic inhibin production after RP could explain the endocrine changes seen after surgery. One study has shown decreased inhibin after simple prostatectomy. 28 According to their data, this effect is specific for PCa, as serum endocrine levels did not change after TURP for BPH and correlated highly with tumor grade. In animal and cell culture models, inhibin produced in the testes and prostate can inhibit the production and secretion of pituitary gonadotropins. 29, 30 Ghosh et al. 31 noted that levels of T and enzymes involved in T production increased in rats following prostatectomy. Studies of inhibin have been limited to animal prostates, so the role of inhibin in human prostate tissue has not been well defined. Moreover, Risbridger et al. 32 evaluated tumor expression of inhibin-a in 174 RP specimens and concluded that elevated expression of inhibin-a is related to higher risk of PSA failure. Yamamoto et al. 33 also noted an increase in T following RP, with a greater increase seen in the low T group than the normal-T group.
In the present study, serum T level was significantly increased after RP compared with preoperative level. As with T, serum LH level after surgery was significantly elevated compared to the preoperative level. These findings support the possibility that PCa may inhibit serum T levels by negative feedback in the hypothalamic-pituitary axis. In addition, differences in serum T levels according to pathological stage disappeared postoperatively. This finding may substantiate the present hypothesis.
However, the point during the natural history of PCa at which malignant tumors begin to impact on androgen biosynthesis and metabolism remains unknown, and no data comparing pre-and postdiagnostic serum levels of androgens within the same subject are available to provide any insight into the extent of changes in hormone levels in relation to malignant growth. Although such comparisons would be informative, methodological issues such as treatment effects, stress related to surgery and weight loss are considered related to malignancy, and may affect serum levels of hormones in postdiagnostic blood, thereby influencing the validity of the comparison between pre-and postdiagnostic serum androgens.
The limitations of the present study include the retrospective nature of the investigation and diurnal variations in androgen, which were not accounted for in this study. However, all tests were processed at the same laboratory. The precise reasons that lead to the request for T measurement were unknown. Body mass index and sex hormone-binding globulin, which can affect T levels, were unavailable in this study. Most investigators assessed sex steroid hormone concentrations at one time point in midlife, although the etiologically relevant time period is unknown. Nevertheless, Platz et al. 9 showed a good correlation between two measures of each hormone in blood taken an average of 3 years apart in a subset of men in their cohort, suggesting that a single measurement is reasonably representative of circulating hormone levels in middle age.
In addition, no association was identified between pretreatment serum T level and pathological Gleason score. This study was limited by the retrospective design and small population size. Further studies with large clinical trials are needed to further clarify relationships between serum T levels and PCa.
Conclusion
In the present study, serum T and LH levels were significantly increased after RP, compared to preoperative Radical prostatectomy and serum testosterone T Imamoto et al levels. This suggests that serum T levels are altered by the presence of PCa, supporting the possibility that PCa may inhibit serum T levels by negative feedback in the hypothalamic-pituitary axis.
